Going against tradition

Article

When you attend an ophthalmology congress, what is it that you expect to gain? Does the opportunity to mingle with the elite inspire you to pay your congress fee, or do you want to learn new skills and improve your everyday practice? Certainly, people's motivations have been somewhat ambiguous in the past. With the style of the traditional meetings placing more emphasis on lecture-type presentations with no real discussion and less emphasis on the sharing of knowledge amongst participants, meeting attendees rarely had any input whatsoever.

Elsewhere, we focus on pharmaceutical therapies in ophthalmology. A bitter pill to swallow provides a good review of the medications most frequently used in an ophthalmologist's everyday practice and urges us to ask the question "Do we really know the side effects of the drugs we give our patients".

As always, please do keep your suggestions and article submissions coming in to Ophthalmology Times Europe.

Happy reading.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.